152 results
·
19ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT ASSAY
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UroVysion Bladder Cancer Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·URO VYSION BLADDER CANCER KIT ASSAY
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UroVysion Bladder Cancer Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UroVysion Bladder Cancer Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·URO VYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UroVysion Bladder Cancer Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·Urovysion Bladder Cancer Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Device, Removal, Pacemaker Electrode, Percutaneous
FDA Pre-Market Approval
FDA Class 3
·SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM & LASER SHEATH
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·PATHVYSION HER-2 DNA PROBE KIT
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT,PROBECHEK ALK POSITIVE CONTROL SLIDES KIT,PROBECHEK ALK NEGATIVE CONTROL SLIDES KIT
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·PATH VYSION HER-2 DNA PROBE KIT